CAS 1305115-80-3

PF-04957325

CAS: 1305115-80-3

PF-04957325

Purezza: ≥98%

Peso molecolare: 400.38g/mol

Ref: 54-BUP04143

PF-04957325

CAS: 1305115-80-3

PF-04957325 is a drug that inhibits phosphodiesterase enzymes. It has been shown to inhibit cyclic nucleotide phosphodiesterases, which are enzymes that break down cyclic nucleotides, preventing the accumulation of cAMP in cells. This accumulation leads to cell death and cancer cell death. PF-04957325 has shown promising effects in animal models for breast cancer treatment. It also has shown synergistic effect with other drugs, such as camp levels and potential drug targets for autoimmune diseases and brain functions. PF-04957325 is effective against cancer tissues and inhibits phosphorylation of the inhibitor protein (IκB), leading to increased production of proinflammatory cytokines.

Formula: C₁₄H₁₅F₃N₈OS

Purezza: Min. 95%

Peso molecolare: 400.38 g/mol

Ref: 3D-FCC11580

PF-04957325

CAS: 1305115-80-3

PF-04957325 is an inhibitor of PDE8.PF-04957325 has an IC50 of 0.7 nM for PDE8A.PF-04957325 can be used for the study of autoimmune encephalomyelitis.

Formula: C₁₄H₁₅F₃N₈OS

Purezza: 99.02%

Colore e forma: Solid

Peso molecolare: 400.38

Ref: TM-T12422